结直肠癌筛查对异时性转移后生存的影响
该研究基于全国登记数据,纳入794例2015年1月至6月诊断为I-III期结直肠癌后发生异时性转移的患者,分析原发肿瘤检出方式(粪便免疫化学检测筛查检出 vs 非筛查检出)与异时性转移后总生存的关联。筛查检出组(n=152)异时性转移后中位总生存和5年总生存均显著高于非筛查检出组(n=642):38.3 vs 19.2个月,35.4% vs 18.8%,p<0.0001;校正混杂因素后关联仍显著(HR 0.70,95%CI 0.56-0.89)。
要点
- 筛查检出原发肿瘤者异时性转移后中位总生存38.3个月,非筛查检出者19.2个月,p<0.0001。
- 筛查检出组5年总生存35.4%,非筛查检出组18.8%,差异显著。
- 校正混杂因素后,筛查检出与异时性转移后更长总生存独立相关(HR 0.70,95%CI 0.56-0.89)。
核心结论
- 原发肿瘤经筛查检出与异时性转移后更长总生存独立相关。
- 作者认为这可能支持人群筛查项目的临床效用,并显示原发肿瘤检出方式在诊断异时性转移后的预后价值。
研究设计与样本
- 基于全国登记数据,纳入2015年1月至6月诊断为I-III期结直肠癌后发生异时性转移的794例患者。
- 采用多变量Cox比例风险回归模型分析原发肿瘤检出方式(FIT筛查检出 vs 非筛查检出)与异时性转移后总生存的关联,并校正潜在混杂因素。
主要发现
- 筛查检出原发肿瘤组(n=152)异时性转移后中位总生存38.3个月,非筛查检出组(n=642)19.2个月,p<0.0001。
- 筛查检出组异时性转移后5年总生存35.4%,非筛查检出组18.8%,p<0.0001。
- 校正潜在混杂因素后,筛查检出与非筛查检出相比,异时性转移后总生存的HR为0.70(95%CI 0.56-0.89)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increasing proportion of colorectal cancer (CRC) cases in Europe are detected by screening with faecal immunochemical testing (FIT). Previous studies showed that population screening with FIT leads to a decrease in CRC incidence and to detection at an earlier stage. However, approximately twenty percent of patients with CRC without metastases at initial diagnosis still develop metachronous metastases. We investigated the association between detection mode of the primary tumor and overall survival (OS) after metachronous metastasis in patients with CRC. METHODS: Nationwide registry-based data was obtained of 794 patients who developed metachronous metastases after being diagnosed with stage I-III CRC between January and June 2015. With multivariable Cox PH regression modelling, we analyzed the (causal) association between detection mode of the primary tumor (FIT screen-detected versus non-screen-detected) and OS after metachronous metastasis while adjusting for potential confounders. RESULTS: Median OS and five-year OS after metachronous metastasis were significantly higher for patients with screen-detected (n = 152) vs. non-screen-detected primary tumors (n = 642): 38.3 vs. 19.2 months, and 35.4% vs. 18.8%, respectively, p < 0.0001). After adjustment for potential confounders, the association between detection mode and OS after metachronous metastasis remained significant (HR 0.70 [95% CI 0.56-0.89]). CONCLUSIONS: Screen-detection of the primary tumor was independently associated with longer OS after metachronous metastasis. This may support the clinical utility of the population screening program and it shows the prognostic value of detection mode of the primary tumor once metachronous metastasis is diagnosed.
引用
- Hamers PAH, Vink GR, Elferink MAG, et al. Impact of colorectal cancer screening on survival after metachronous metastasis. Eur J Cancer. 2023. PMID: 38006758. doi:10.1016/j.ejca.2023.113429
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。